Skip to main content
Signal8

Windward Bio Lists on Nasdaq, Shares Up 68% on Debut

$WWBPress releaseNov 16, 2026, 8:28 AM ETRead the release

Windward Bio Group AG (Nasdaq: WWB) began trading on Nov. 13, 2026, pricing its IPO at $17.00 per share and raising $225 million in gross proceeds, including a $50 million concurrent private placement from Sanofi. Shares closed the first day up 68%, putting the market capitalization at roughly $1.69 billion — less than two years after the company's 2024 founding. The Basel-based, clinical-stage biotech develops ultra-long-acting antibodies for respiratory and dermatologic diseases.

Key figures

Deal Value Usd
225000000
Offering Price
17
Shares Offered
10290000
Series a
$200 million (January 2025)
Crossover financing
$165 million (May 2026)
Ipo premium day one
68%
Market cap post debut
1690000000
Concurrent private placement
$50 million from Sanofi
Total raised since inception
$365 million

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.